A large observational study published in Headache (2007;47(1):73–80) examined coenzyme Q10 (CoQ10) status in children and young adults with frequent headaches. The study included 1,550 participants between the ages of 3 and 22.
CoQ10 deficiency was common in this group. Approximately 75% of participants were found to have low CoQ10 levels, and nearly half of those had values below the established reference range. Participants identified as having low CoQ10 levels were supplemented with CoQ10 at doses ranging from 1 to 3 mg per kilogram of body weight per day.
After an average of 97 days of supplementation, 250 participants were re-evaluated. Plasma CoQ10 levels increased, and headache frequency declined. More than 46% of these individuals experienced at least a 50% reduction in headache frequency.
These findings suggest that low CoQ10 levels are common in pediatric and young adult headache populations and that restoring CoQ10 levels may be associated with meaningful reductions in headache frequency. As an observational follow-up, the results highlight an association rather than causation, but they support further investigation into CoQ10 status as a factor in headache management.
